✦ LIBER ✦

Physician and pharmacist perceptions of generic drugs

✍ Scribed by William O. Bearden; Joseph Barry Mason

Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 449 KB
Volume: 8
Category: Article
ISSN: 0019-8501
DOI: 10.1016/0019-8501(79)90020-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survey of pharmacists’ and physicians’ p

Survey of pharmacists’ and physicians’ perceptions of therapeutic interchange

✍ Timothy A. Poole 📂 Article 📅 2005 🏛 Springer Healthcare Communications 🌐 English ⚖ 323 KB

The Relations of Pharmacists, Physicians

The Relations of Pharmacists, Physicians and Nostrums

✍ Dr. G. Vulpius 📂 Article 📅 1876 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Quality of adverse drug experience repor

Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA

✍ Syed Rizwanuddin Ahmad; Joel P. Freiman; David J. Graham; Robert C. Nelson 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

The US Food and Drug Administration (FDA)'s Spontaneous Adverse Experience Reporting System is a computerized database with over one million adverse drug experience (ADE) reports. In 1992, the FDA received over 100,000 ADE reports and pharmacists were major contributors to these reports. In 1993, th

Knowledge, attitudes, and perceptions of

Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran

✍ Vessal, Ghazal ;Mardani, Zeinab ;Mollai, Mehri 📂 Article 📅 2008 🏛 Springer 🌐 Dutch ⚖ 159 KB

Physician-pharmacist collaborative care

Physician-pharmacist collaborative care for dyslipidemia patients: Knowledge and skills of community pharmacists

✍ Julie Villeneuve; Diane Lamarre; Marie-Thérèse Lussier; Marie-Claude Vanier; Jac 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Assessing bioequivalence of generic anti

Assessing bioequivalence of generic antiepilepsy drugs

✍ Gregory L. Krauss; Brian Caffo; Yi-Ting Chang; Craig W. Hendrix; Kelly Chuang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

## Objective: Patients with epilepsy are often concerned that switching between brand-name and generic formulations of antiepilepsy drugs (aeds) may cause clinically significant changes in plasma drug concentrations. we assessed bioequivalence (be) studies for approved generic aeds to evaluate us f